Azzad Asset Management’s 10x Genomics TXG Stock Holding History

Azzad Asset Management’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$226K	Buy	+5,886	New	+$154K	0.02%	342
2021 Q4	–	Sell	-4,666	Closed	-$679K	–	340
2021 Q3	$679K	Buy	4,666 +22	+0.5%	+$3.78K	0.1%	266
2021 Q2	$909K	Buy	4,644 +94	+2%	+$17K	0.14%	239
2021 Q1	$823K	Buy	4,550 +589	+15%	+$102K	0.14%	232
2020 Q4	$561K	Buy	+3,961	New	+$575K	0.1%	241

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Azzad Asset Management's TXG Position: Q2 2026 in Review

Azzad Asset Management opened a new position in 10x Genomics (TXG) in Q2 2026: 5,886 shares worth $226K. The stake represents 0.02% of the portfolio and ranks #342 among its holdings. This is a return to the name: Azzad Asset Management previously reported a position in TXG as recently as Q3 2021.

Azzad Asset Management first reported a position in TXG in Q4 2020 and has held it in 5 quarters since. The position peaked at $909K in Q2 2021. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Azzad Asset Management held 5,886 shares of 10x Genomics worth $226K as of Q2 2026.
10x Genomics was a new Azzad Asset Management position in Q2 2026.
10x Genomics made up 0.02% of Azzad Asset Management's portfolio in Q2 2026, its #342 holding.
Azzad Asset Management first reported a position in 10x Genomics in Q4 2020 and has held it in 5 quarters since.
Azzad Asset Management's 10x Genomics position peaked at $909K in Q2 2021.
392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Azzad Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.